ScoreWhy is Shandong Wohua Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -4.69% and Operating profit at -12.59% over the last 5 years
2
The company has declared Positive results for the last 3 consecutive quarters
- ROCE(HY) Highest at 15.68%
- INTEREST COVERAGE RATIO(Q) Highest at 420,439.78
- RAW MATERIAL COST(Y) Fallen by -8.27% (YoY)
3
With ROE of 15.55%, it has a expensive valuation with a 5.04 Price to Book Value
- Over the past year, while the stock has generated a return of 6.02%, its profits have risen by 123.2% ; the PEG ratio of the company is 0.3
4
Underperformed the market in the last 1 year
- The stock has generated a return of 6.02% in the last 1 year, much lower than market (China Shanghai Composite) returns of 16.83%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Shandong Wohua Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shandong Wohua Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Shandong Wohua Pharmaceutical Co., Ltd.
-10.26%
1.27
43.28%
China Shanghai Composite
8.25%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-4.69%
EBIT Growth (5y)
-12.59%
EBIT to Interest (avg)
85.22
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.56
Sales to Capital Employed (avg)
1.12
Tax Ratio
13.05%
Dividend Payout Ratio
160.43%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.50%
ROE (avg)
12.98%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
31
Industry P/E
Price to Book Value
4.78
EV to EBIT
25.69
EV to EBITDA
21.28
EV to Capital Employed
9.41
EV to Sales
3.50
PEG Ratio
0.25
Dividend Yield
4.75%
ROCE (Latest)
36.65%
ROE (Latest)
15.55%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
INTEREST COVERAGE RATIO(Q)
Highest at 499,316.9
OPERATING CASH FLOW(Y)
Highest at CNY 134.59 MM
NET PROFIT(HY)
At CNY 67.57 MM has Grown at 51.23%
ROCE(HY)
Highest at 16.37%
DEBTORS TURNOVER RATIO(HY)
Highest at 11.23 times
OPERATING PROFIT MARGIN(Q)
Highest at 24.99 %
RAW MATERIAL COST(Y)
Fallen by -2.69% (YoY
-3What is not working for the Company
NET SALES(Q)
Lowest at CNY 174.3 MM
Here's what is working for Shandong Wohua Pharmaceutical Co., Ltd.
Interest Coverage Ratio
Highest at 499,316.9 and Grown
In each period in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Operating Profit Margin
Highest at 24.99 % and Grown
In each period in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Net Profit
At CNY 67.57 MM has Grown at 51.23%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Debtors Turnover Ratio
Highest at 11.23 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Operating Cash Flow
Highest at CNY 134.59 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Raw Material Cost
Fallen by -2.69% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Shandong Wohua Pharmaceutical Co., Ltd.
Net Sales
At CNY 174.3 MM has Fallen at -14.78%
over average net sales of the previous four periods of CNY 204.54 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Net Sales
Lowest at CNY 174.3 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
